CHina Adrenal Venous saMPling InvestigatiON (CHAMPION)
China Adrenal Venous Sampling Investigation: Eine nationale multizentrische Studie
Primary aldosteronism (PA) is a major cause of secondary hypertension, yet its optimal diagnosis and management remain challenging. This study comprehensively evaluates adrenal venous sampling (AVS), addressing key clinical, technical, and methodological issues, and aims to clarify the relationship between AVS-guided management and long-term clinical and biochemical outcomes to optimize patient care and prognosis.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, yet its optimal diagnostic and therapeutic strategies remain challenging. Adrenal venous sampling (AVS) is regarded as the gold standard for subtype differentiation; however, important clinical, technical, and methodological issues have not been systematically addressed. This study is designed to comprehensively evaluate AVS and its clinical implications, aiming to elucidate the relationship between AVS-guided diagnosis and management of PA and long-term clinical and biochemical outcomes, while refining AVS protocols, standardizing clinical practice, optimizing therapeutic decision-making, and ultimately improving patient management and prognosis.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Hui Dong, MD
- Telefonnummer: 86-010-88322385
- E-Mail: donghui666@sina.com
Studieren Sie die Kontaktsicherung
- Name: Xiongjing Jiang, MD
- Telefonnummer: 86-010-88322387
- E-Mail: jiangxiongjing@163.com
Studienorte
-
-
Anhui
-
Hefei, Anhui, China, 230036
- Rekrutierung
- The first affiliated hospital of USTC
-
Kontakt:
- Xiangyong Kong, PhD
- Telefonnummer: 0551-62284055
- E-Mail: kxyong1234@163.com
-
Hauptermittler:
- Xiangyong Kong, PhD
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100034
- Rekrutierung
- Peking University First Hospital
-
Hauptermittler:
- Wei Ma, MD
-
Kontakt:
- Wei Ma, MD
- Telefonnummer: 13681050902
- E-Mail: kmmawei@sina.com
-
Beijing, Beijing Municipality, China, 100044
- Rekrutierung
- Peking University People's Hospital
-
Kontakt:
- Jing Liu, MD
- Telefonnummer: 010-66583710
- E-Mail: heartcenter@163.com
-
Hauptermittler:
- Jing Liu, MD
-
Beijing, Beijing Municipality, China, 100029
- Rekrutierung
- China-Japan Friendship Hospital
-
Hauptermittler:
- Wuqiang Che, MD
-
Kontakt:
- Wuqiang Che, MD
- Telefonnummer: 010-84205136
- E-Mail: chemokel@163.com
-
Beijing, Beijing Municipality, China, 100022
- Rekrutierung
- Chuiyangliu Hospital affiliated to Tsinghua University
-
Hauptermittler:
- Lin Pi, MD
-
Kontakt:
- Lin Pi, MD
- Telefonnummer: 010-87766377
- E-Mail: pilindoctor@126.com
-
Beijing, Beijing Municipality, China, 100037
- Rekrutierung
- Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
-
Hauptermittler:
- Hui Dong, MD
-
Kontakt:
- Hui Dong, MD
- Telefonnummer: 86-010-88322385
- E-Mail: donghui666@sina.com
-
Kontakt:
- Xiongjing Jiang, MD
- Telefonnummer: 86-010-88322387
- E-Mail: jiangxiongjing@163.com
-
Beijing, Beijing Municipality, China, 101100
- Rekrutierung
- Beijing Luhe Hospital, Capital Medical University
-
Kontakt:
- Dong Zhao, MD, PhD
- Telefonnummer: 010-69543901
- E-Mail: zhaodong@ccmu.edu.cn
-
Hauptermittler:
- Dong Zhao, MD, PhD
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, China, 400000
- Rekrutierung
- Chongqing University Central Hospital
-
Hauptermittler:
- Dongying Zhang, MD
-
Kontakt:
- Dongying Zhang, MD
- Telefonnummer: 13608398395
- E-Mail: zhangdongying@cqmu.edu.cn
-
Chongqing, Chongqing Municipality, China, 401147
- Rekrutierung
- Chongqing General Hospital
-
Hauptermittler:
- Rui He, MM
-
Kontakt:
- Rui He, MM
- Telefonnummer: 023-63390560
- E-Mail: 253942231@qq.com
-
Chongqing, Chongqing Municipality, China, 404100
- Rekrutierung
- People's Hospital Affiliated to ChongqingThree Gorges Medical college
-
Hauptermittler:
- Xianhu Luo, MD
-
Kontakt:
- Xianhu Luo, MD
- Telefonnummer: 15923433929
- E-Mail: 826863635@qq.com
-
-
Fujian
-
Fuzhou, Fujian, China, 0591-87982222
- Rekrutierung
- First Affiliated Hospital, Fujian Medical University, Fuzhou, China,
-
Kontakt:
- Feng Peng, MD
- Telefonnummer: 0591-87982222
- E-Mail: pengfeng@fjmu.edu.cn
-
Hauptermittler:
- Feng Peng, MD
-
Xiamen, Fujian, China, 361016
- Rekrutierung
- Cardiovascular Hospital Xiamen University
-
Hauptermittler:
- Tao Ye, MD
-
Kontakt:
- Tao Ye, MD
- Telefonnummer: 029-2292337
- E-Mail: yetao@xmu.edu.cn
-
-
Gansu
-
Lanzhou, Gansu, China, 730000
- Rekrutierung
- Lanzhou University Second Hospital
-
Hauptermittler:
- Wei Liang, MD
-
Kontakt:
- Wei Liang, MD
- Telefonnummer: 0931-5190690
- E-Mail: 758099072@qq.com
-
-
Guangdong
-
Foshan, Guangdong, China, 528211
- Rekrutierung
- The Forth People's Hosptal of Nanhai District of Foshan City
-
Hauptermittler:
- Yayan Han, MD
-
Kontakt:
- Yayan Han, MD
- Telefonnummer: 0757-86866918
- E-Mail: hyy321521@sohu.com
-
Guangzhou, Guangdong, China, 510080
- Rekrutierung
- Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
-
Hauptermittler:
- Yingqing Feng, MD
-
Kontakt:
- Yingqing Feng, MD
- Telefonnummer: 13602863389
- E-Mail: fyq1819@163.com
-
Shenzhen, Guangdong, China, 518000
- Rekrutierung
- Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen
-
Kontakt:
- Jianqiong Kong, MD
- Telefonnummer: 13510568376
- E-Mail: 2653290915@qq.com
-
Hauptermittler:
- Jianqiong Kong, MD
-
Shenzhen, Guangdong, China, 518112
- Rekrutierung
- Shenzhen Third People's Hospital,Shenzhen, Guangdong Province 518112, China
-
Kontakt:
- Zhenzhong Zheng, MD, PhD
- Telefonnummer: 0755-61222333
- E-Mail: greateful@163.com
-
Hauptermittler:
- Zhenzhong Zheng, MD, PhD
-
Shenzhen, Guangdong, China, 518116
- Rekrutierung
- Shenzhen Dapeng New District Kuiyong People's Hospital
-
Hauptermittler:
- Tongqing Lu, MD
-
Kontakt:
- Tongqing Lu, MD
- Telefonnummer: 0755-84204067
- E-Mail: lutongqing@hotmail.com
-
-
Guangxi
-
Nanning, Guangxi, China, 530000
- Rekrutierung
- The First Affiliated Hospital of Guangxi Medical University
-
Hauptermittler:
- Jiangnan Huang, MD
-
Kontakt:
- Jiangnan Huang, MD
- Telefonnummer: 07715359553
- E-Mail: huangjn1998@163.com
-
Nanning, Guangxi, China, 530007
- Rekrutierung
- The Second Affliated Hospital Of GuangXi Medical Univesity
-
Kontakt:
- Houfa Ning, MM
- Telefonnummer: 0771-3277215
- E-Mail: houfa.ning@foxmail.com
-
Hauptermittler:
- Houfa Ning, MM
-
Nanning, Guangxi, China, 547000
- Rekrutierung
- Nanning Third People's Hospital
-
Kontakt:
- Yongqi Xiao, MBBS
- Telefonnummer: 07713394390
-
Hauptermittler:
- Yongqi Xiao, MBBS
-
-
Guizhou
-
Guiyang, Guizhou, China, 550004
- Rekrutierung
- The Affiliated Hospital of Guizhou Medical University
-
Kontakt:
- Zhangrong Chen, MD
- Telefonnummer: 0856-88689263
- E-Mail: chenzhangrong71@163.com
-
Hauptermittler:
- Zhangrong Chen, MD
-
Guiyang, Guizhou, China, 550002
- Rekrutierung
- Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, China.
-
Kontakt:
- Fang Song, MD
- Telefonnummer: 18685191199
- E-Mail: songfangheart@126.com
-
Hauptermittler:
- Fang Song, MD
-
Kaili, Guizhou, China, 556000
- Rekrutierung
- The Second Affiliated Hospital Of Guizhou Medical University
-
Hauptermittler:
- Yumei Xiang, MD
-
Kontakt:
- Yumei Xiang, MD
- Telefonnummer: 0855-3833103
- E-Mail: 1016313267@qq.com
-
-
Hainan
-
Haikou, Hainan, China, 570311
- Rekrutierung
- Hainan General Hospital, Department of Endocrinology
-
Kontakt:
- Haiyu Zhang, MM
- Telefonnummer: 0898-68622221
- E-Mail: yuhai_2013@163.com
-
Hauptermittler:
- Haiyu Zhang, MM
-
Hainan, Hainan, China, 570311
- Rekrutierung
- Hainan General Hospital, Department of Cardiology
-
Kontakt:
- Wang Liao, MD
- Telefonnummer: 13518827831
- E-Mail: crain_lw@163.com
-
Hauptermittler:
- Wang Liao, MD
-
-
Hebei
-
Tangshan, Hebei, China, 063000
- Rekrutierung
- Tangshan hongci Hospital
-
Hauptermittler:
- Guijuan Zhang, MD
-
Kontakt:
- Guijuan Zhang, MD
- Telefonnummer: 0315-6272993
- E-Mail: zhangguijun1212@63.com
-
-
Heilongjiang
-
Harbin, Heilongjiang, China, 150086
- Rekrutierung
- The Second Affiliated Hospital of Harbin Medical University
-
Kontakt:
- Shuo Zhang, MD
- Telefonnummer: 18645056661
- E-Mail: zhangshuoemail@163.com
-
Hauptermittler:
- Shuo Zhang, MD
-
Harbin, Heilongjiang, China, 150001
- Rekrutierung
- The First Affiliated Hospital of Harbin Medical University
-
Hauptermittler:
- Dechao Zhao, MD
-
Kontakt:
- Dechao Zhao, MD
- Telefonnummer: 0451-85555723
- E-Mail: drzhaodechao@163.com
-
-
Henan
-
Kaifeng, Henan, China, 475002
- Rekrutierung
- Kai Feng the Peoples Hospital
-
Kontakt:
- Qingli Pan, MD
- Telefonnummer: 0371-22730719
- E-Mail: 742642136@qq.com
-
Hauptermittler:
- Qingli Pan, MD
-
Zhengzhou, Henan, China, 450052
- Rekrutierung
- The First Affiliated Hospital of Zhengzhou University
-
Kontakt:
- Youyou Du, MD
- Telefonnummer: 0371-67966613
- E-Mail: duyouyou_008@163.com
-
Hauptermittler:
- Youyou Du, MD
-
Zhengzhou, Henan, China, 450003
- Rekrutierung
- Henan Provincial People's Hospital
-
Hauptermittler:
- Min Liu, MD
-
Kontakt:
- Min Liu, MD
- Telefonnummer: 0371-65586642
- E-Mail: liumin136@126.com
-
Zhengzhou, Henan, China, 450000
- Rekrutierung
- Fuwai Central China Cardiovascular Hospital
-
Hauptermittler:
- Qiuping Zhao, PhD
-
Kontakt:
- Qiuping Zhao, PhD
- Telefonnummer: 0371-58681170
- E-Mail: qiupingzhao@zzu.edu.cn
-
Zhengzhou, Henan, China, 450018
- Rekrutierung
- Zhengzhou Yihe Hospital
-
Kontakt:
- Liang An, MD
- Telefonnummer: 0371-56570913
- E-Mail: 184530063@qq.com
-
Hauptermittler:
- Liang An, MD
-
Zhengzhou, Henan, China, 450007
- Rekrutierung
- Zhengzhou Central Hospital Affiliated to Zhengzhou University
-
Hauptermittler:
- Shuhua Yu, MM
-
Kontakt:
- Shuhua Yu, MM
- Telefonnummer: 0371-67690941
- E-Mail: 13613716677@139.com
-
Zhoukou, Henan, China, 466000
- Rekrutierung
- Zhoukou Central Hospital
-
Hauptermittler:
- Baogong Wang, MD
-
Kontakt:
- Baogong Wang, MD
- Telefonnummer: 0394-8521613
- E-Mail: 598634874@qq.com
-
-
Hubei
-
Wuhan, Hubei, China, 430060
- Rekrutierung
- Renmin Hospital of Wuhan University
-
Kontakt:
- Hongxin Xu, MD
- Telefonnummer: 18908640597
- E-Mail: 303876340@qq.com
-
Hauptermittler:
- Hongxin Xu, MD
-
Xiangyang, Hubei, China, 441021
- Rekrutierung
- Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
-
Kontakt:
- Qingan Li, MD
- Telefonnummer: 0710-2811051
- E-Mail: 2145439882@qq.com
-
Hauptermittler:
- Qingan Li, MD
-
Yichang, Hubei, China, 43000
- Rekrutierung
- Yichang Central People's Hospital
-
Hauptermittler:
- Yunbo Lv, MD
-
Kontakt:
- Yunbo Lv, MD
- Telefonnummer: 0717-6229791
- E-Mail: 362435582@qq.com
-
-
Hunan
-
Zhuzhou, Hunan, China, 412000
- Rekrutierung
- Zhuzhou Hospital Affiliated to Xiangya School of Medicine,Central South University
-
Kontakt:
- Liang Tang, MBBS
- Telefonnummer: 0733-28561703
-
Hauptermittler:
- Liang Tang, MBBS
-
-
Jiangsu
-
Xuzhou, Jiangsu, China, 221009
- Rekrutierung
- Xuzhou Central Hospital, Jiangsu
-
Kontakt:
- Hongyun Ruan, MD
- Telefonnummer: 0516-83985031
- E-Mail: hongyunruan@163.com
-
Hauptermittler:
- Hongyun Ruan, MD
-
-
Jiangxi
-
Ganzhou, Jiangxi, China, 341000
- Rekrutierung
- The First Affiliated Hospital of Gannan Medical University
-
Kontakt:
- Jiayuan Ling, MD
- Telefonnummer: 18807972012
- E-Mail: 15803152@qq.com
-
Hauptermittler:
- Jiayuan Yuan, MD
-
Nanchang, Jiangxi, China, 330006
- Rekrutierung
- Second Affiliated Hospital of Nanchang University
-
Kontakt:
- Yifei Dong, MD, PhD
- Telefonnummer: 0791-8735-7354
- E-Mail: yf_dong66@126.com
-
Hauptermittler:
- Yifei Dong, MD, PhD
-
Nanchang, Jiangxi, China, 330038
- Rekrutierung
- Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
-
Hauptermittler:
- Haohang Ruan, MBBS
-
Kontakt:
- Haohang Ruan, MBBS
- Telefonnummer: 0791-87721036
-
-
Jilin
-
Changchun, Jilin, China, 130021
- Rekrutierung
- The First Hospital of Jilin University
-
Kontakt:
- Wei Zhao, MD
- Telefonnummer: 0431-88782342
- E-Mail: w_zhao@jlu.edu.cn
-
Hauptermittler:
- Wei Zhao, MD
-
Changchun, Jilin, China, 130051
- Rekrutierung
- Jilin Province FAW General Hospital
-
Hauptermittler:
- Wenhai Wang, MM
-
Kontakt:
- Wenhai Wang, MM
- Telefonnummer: 043185904542
- E-Mail: 767732002@qq.com
-
-
Liaoning
-
Dalian, Liaoning, China, 116001
- Rekrutierung
- Affilated Zhongshan Hospital of Dalian University
-
Kontakt:
- Minglian Gong, MD
- Telefonnummer: 0411-62896223
- E-Mail: gongml777@126.com
-
Hauptermittler:
- Minglian Gong, MD
-
Dalian, Liaoning, China, 116011
- Rekrutierung
- Frist Aiffiliated Hospital of Dalian Medical University
-
Hauptermittler:
- Yinong Jiang, MD
-
Kontakt:
- Yinong Jiang, MD
- Telefonnummer: 0411-83635963
- E-Mail: yinongjiang@163.com
-
Dalian, Liaoning, China, 116027
- Rekrutierung
- The second hospital of Dalian Medical University
-
Kontakt:
- Nan Niu, MD
- Telefonnummer: 17709875885
- E-Mail: nn_6581@aliyun.com
-
Hauptermittler:
- Nan Niu, MD
-
-
Neimenggu
-
Ulanhot, Neimenggu, China, 137400
- Rekrutierung
- Inner Mongolia Xing'an League People's Hospital
-
Kontakt:
- Tao Guo, MM
- Telefonnummer: 0482-8282080
- E-Mail: guot18@lzu.edu.cn
-
Hauptermittler:
- Tao Guo, MM
-
-
Ningxia
-
Yinchuan, Ningxia, China, 750000
- Rekrutierung
- The First People's Hospital of Yinchuan
-
Kontakt:
- Fang Chen, PhD
- Telefonnummer: 13895008699
- E-Mail: cf720302@126.com
-
Hauptermittler:
- Fang Chen, PhD
-
-
Qinghai
-
Xining, Qinghai, China, 810001
- Rekrutierung
- Qinghai University Affiliated Hospital
-
Kontakt:
- Ming Ren, MM
- Telefonnummer: 13709788862
- E-Mail: qhrm-0971@163.com
-
Hauptermittler:
- Ming Ren, MM
-
Xining, Qinghai, China, 810000
- Rekrutierung
- Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital
-
Kontakt:
- Xiaozhou Wang, MD
- Telefonnummer: 0971-6288407
- E-Mail: wxz_1978@163.com
-
Hauptermittler:
- Xiaozhou Wang, MD
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Rekrutierung
- Qilu Hospital of Shandong University
-
Hauptermittler:
- Peili Bu, MD
-
Kontakt:
- Peili Bu, MD
- Telefonnummer: 18560086596
- E-Mail: bupeili@medmail.com.cn
-
Jinan, Shandong, China, 250013
- Rekrutierung
- Central Hospital Affiliated to Shandong First Medical University
-
Kontakt:
- Rui Xu, MD, PhD
- Telefonnummer: 0531-88653212
- E-Mail: xuruicn@hotmail.com
-
Hauptermittler:
- Rui Xu, MD, PhD
-
Jinan, Shandong, China, 250000
- Rekrutierung
- the Second Hospital, Cheeloo College of Medicine, Shandong University
-
Kontakt:
- Qinghai Wang, MD
- Telefonnummer: 0543-85875088
- E-Mail: sdwqh1005@126.com
-
Hauptermittler:
- Qinghai Wang, MD
-
Liaocheng, Shandong, China, 252200
- Rekrutierung
- People's Hospital of Donga County, Shandong Province
-
Hauptermittler:
- Xiaoli Wang, MD
-
Kontakt:
- Xiaoli Wang, MD
- Telefonnummer: 15865751121
- E-Mail: w15865751121@126.com
-
Qingdao, Shandong, China, 266000
- Rekrutierung
- Qingdao Hospital University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)
-
Kontakt:
- Nan Jia, MD
- Telefonnummer: 17669783012
- E-Mail: jiananchina@qq.com
-
Hauptermittler:
- Nan Jia, MD
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200025
- Rekrutierung
- Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
-
Kontakt:
- Jiangzhong Xu, MD, PhD
- Telefonnummer: 13761452329
- E-Mail: jianzhongxv@outlook.com
-
Hauptermittler:
- Jianzhong Xu, MD, PhD
-
Shanghai, Shanghai Municipality, China, 200062
- Rekrutierung
- Shanghai Putuo District Central Hospital
-
Hauptermittler:
- Zongjun Liu, MD
-
Kontakt:
- Zongjun Liu, MD
- Telefonnummer: 021-22233222
- E-Mail: liuzongjun1548@shutcm.edu.cn
-
Shanghai, Shanghai Municipality, China, 200080
- Rekrutierung
- Shanghai General Hospital ( originally named Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine
-
Kontakt:
- Zhi Zhang, MD
- Telefonnummer: 13621759762
- E-Mail: 16683890@qq.com
-
Hauptermittler:
- Zhi Zhang, MD
-
-
Shanxi
-
Taiyuan, Shanxi, China, 030001
- Rekrutierung
- the second hospital of ShanXi medical unversity
-
Hauptermittler:
- Bin Yang, MD
-
Kontakt:
- Bin Yang, MD
- Telefonnummer: 13546355355
- E-Mail: yangbxys@163.com
-
Xi’an, Shanxi, China, 710018
- Rekrutierung
- Xi'an People's Hospital
-
Kontakt:
- Kang Cheng, MD, PhD
- Telefonnummer: 029-61199240
- E-Mail: chengkang75@126.com
-
Hauptermittler:
- Kang Cheng, MD, PhD
-
-
Sichuan
-
Chengdu, Sichuan, China, 611130
- Rekrutierung
- Chengdu Fifth People's Hospital
-
Hauptermittler:
- Mingjian Lang, MD
-
Kontakt:
- Mingjian Lang
- Telefonnummer: (028) 8271 0681
- E-Mail: zcl628@163.com
-
Chengdu, Sichuan, China, 610500
- Rekrutierung
- The First Affiliated Hospital of Chengdu Medical College
-
Hauptermittler:
- Peijian Wang, MD
-
Kontakt:
- Peijian Wang, MD
- Telefonnummer: 18980718263
- E-Mail: wpjmed@aliyun.com
-
Chengdu, Sichuan, China, 610031
- Rekrutierung
- The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China
-
Hauptermittler:
- Zhen Zhang, MD
-
Kontakt:
- Zhen Zhang, MD
- Telefonnummer: 13708042927
- E-Mail: 31350377@qq.com
-
-
Tianjin Municipality
-
Tianjin, Tianjin Municipality, China, 300052
- Rekrutierung
- Tianjin Medical University General Hospital
-
Hauptermittler:
- Dianxun Fu, MD
-
Kontakt:
- Dianxun Fu, MD
- Telefonnummer: 022-60814078
- E-Mail: cmufudx1@126.com
-
Tianjin, Tianjin Municipality, China, 300211
- Rekrutierung
- The Second Hospital of Tianjin Medical University
-
Hauptermittler:
- Changle Liu, MD
-
Kontakt:
- Changle Liu, MD
- Telefonnummer: 15522133881
- E-Mail: lcl1979_2001@163.com
-
Tianjin, Tianjin Municipality, China, 300457
- Rekrutierung
- TEDA International Cardiovascular Hospital
-
Kontakt:
- Weiqiang Chen, MM
- Telefonnummer: 022-65209995
- E-Mail: 13821205212@163.com
-
Hauptermittler:
- Weiqiang Wang, MM
-
-
Tibet
-
Chamdo, Tibet, China, 854000
- Rekrutierung
- Changdu People's Hospital of Tibet
-
Kontakt:
- Rui Xiang, MD
- Telefonnummer: 0895-4821745
-
Hauptermittler:
- Rui Xiang, MD
-
-
Xinjiang
-
Yining, Xinjiang, China, 835000
- Rekrutierung
- Yili Kazak Autonomous Prefecture Friendship Hospital
-
Kontakt:
- Wei Li, MBBS
- Telefonnummer: 18935778517
- E-Mail: 18935778517@163.com
-
Hauptermittler:
- Wei Li, MBBS
-
Ürümqi, Xinjiang, China, 830001
- Rekrutierung
- Xinjiang Uygur Autonomous Region People's Hospital
-
Kontakt:
- Guoliang Wang, PhD
- Telefonnummer: 0991-8563065
- E-Mail: 908022751@qq.com
-
Hauptermittler:
- Guoliang Wang, PhD
-
-
Yunnan
-
Kunming, Yunnan, China, 650031
- Rekrutierung
- The First Affiliated Hospital of Kunming Medical University
-
Kontakt:
- Lihua Zhang, PhD
- Telefonnummer: 0871-65324888-6133
- E-Mail: lihuazhang772002@163.com
-
Hauptermittler:
- Lihua Zhang, PhD
-
Kunming, Yunnan, China, 650102
- Rekrutierung
- Fuwai Yunnan Cardiovascular Hospital
-
Hauptermittler:
- Zihong Guo, MD
-
Kontakt:
- Zihong Guo, MD
- Telefonnummer: 0871-68515973
- E-Mail: guozihong1962@163.com
-
Kunming, Yunnan, China, 650051
- Rekrutierung
- Yan'an Affiliated Hospital of Kunming Medical University
-
Kontakt:
- Yan He, MD
- Telefonnummer: 0871-63211375
- E-Mail: 1349561462@qq.com
-
Hauptermittler:
- Yan He, MD
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- Rekrutierung
- Zhejiang Hospital
-
Hauptermittler:
- Yimin Tang, MD
-
Kontakt:
- Yimin Tang, MD
- Telefonnummer: 13758176000
- E-Mail: tang5995@aliyun.com
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
All patients with confirmed primary aldosteronism underwent adrenal venous sampling.
Beschreibung
Inclusion Criteria:
- Patients with confirmed primary aldosteronism;
- Patients undergoing adrenal venous sampling for subtype classification of primary aldosteronism.
Exclusion Criteria:
- Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months;
- An estimated glomerular filtration rate <45 ml/min/1.73 m2, or serum creatinine >176 μmol/L;
- Patients who refuse adrenalectomy;
- Suspected of having an adrenocortical carcinoma;
- Allergy to contrast agent;
- Pregnant, nursing, or planning to become pregnant
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: COHORT
- Zeitperspektiven: OTHER
Anzahl der Gruppen / Kohorten
Kohorten und Interventionen
Gruppe / KohorteGruppe / Kohorte |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Adrenal Venous Sampling
Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production. |
Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Major adverse cardiovascular events (MACE) at 1-year follow-up
Zeitfenster: 1 year after AVS procedure
|
Incidence of major adverse cardiovascular events (MACE) at 1-year follow-up, including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death. |
1 year after AVS procedure
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
The success rate of left adrenal venous sampling
Zeitfenster: At AVS procedure
|
Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation) |
At AVS procedure
|
|
The success rate of right adrenal venous sampling
Zeitfenster: At AVS procedure
|
Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation) |
At AVS procedure
|
|
The success rate of bilateral adrenal venous sampling
Zeitfenster: At AVS procedure
|
Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation) |
At AVS procedure
|
|
Selection of intraoperative catheter
Zeitfenster: At AVS procedure
|
Types of catheter at the time of Adrenal Venous Sampling via antecubital approach or femoral approach |
At AVS procedure
|
|
Time of the procedure
Zeitfenster: At AVS procedure
|
Time of the procedure |
At AVS procedure
|
|
Time of fluoroscopy
Zeitfenster: At AVS procedure
|
Time of fluoroscopy |
At AVS procedure
|
|
The contrast agent dosage
Zeitfenster: At AVS procedure
|
The contrast agent dosage |
At AVS procedure
|
|
the incidence of complications
Zeitfenster: 1 week after AVS procedure
|
Complications related to adrenal vein cannulations (adrenal vein hematoma, inferior vena cava dissection, puncture site hematoma, etc) |
1 week after AVS procedure
|
|
the cost of the procedure
Zeitfenster: At AVS procedure
|
the cost of the procedure |
At AVS procedure
|
|
Change in 24-hour ambulatory systolic blood pressure
Zeitfenster: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
The difference in average systolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) between baseline and each follow-up time point. |
At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
|
Change in 24-hour ambulatory diastolic blood pressure
Zeitfenster: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
The difference in average diastolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) bewteen baseline and each follow-up time point. |
At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
|
Change in office systolic blood pressure
Zeitfenster: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
The difference in systolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point |
At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
|
Change in office diastolic blood pressure
Zeitfenster: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
The difference in diastolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point |
At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
|
Change in antihypertensive medication burden
Zeitfenster: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
The change in the number and/or dosage of antihypertensive medications taken by patients between baseline and each follow-up time point |
At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
|
Change in urinary albumin-to-creatinine ratio (UACR)
Zeitfenster: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
The difference in urinary albumin-to-creatinine ratio measured at baseline and at each follow-up time point |
At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
|
Change in left ventricular mass index (LVMI)
Zeitfenster: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
The change in left ventricular mass index, as assessed by echocardiography, from baseline to each follow-up time point. |
At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
|
Change in pulse wave velocity (PWV) from baseline
Zeitfenster: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
The change in pulse wave velocity measured between baseline and each follow-up time point。 |
At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
|
|
Clinical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Zeitfenster: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
|
Clinical outcomes will be assessed at each follow-up visit afteradrenal surgery according to the PASO consensus criteria. Outcomes will be categorized as: (1)Complete clinical success: normal blood pressure without the need for any antihypertensive medication. (2)Partial clinical success: improvement in blood pressure and/or a reduction in the number or dosage of antihypertensive medications. (3)Absent clinical success: no improvement in blood pressure or antihypertensive medication burden. |
At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
|
|
Biochemical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Zeitfenster: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
|
Biochemical outcomes will be assessed at each follow-up visit after adrenal surgery according to the PASO consensus classification. Outcomes will be categorized as:(1)Complete biochemical success: normal serum potassium levels and a normalized aldosterone-to-renin ratio (ARR) without the need for potassium supplementation.(2)Partial biochemical success: improvement in biochemical parameters without full normalization.(3)Absent biochemical success: no improvement in biochemical markers compared to baseline. |
At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
|
|
Major adverse cardiovascular events (MACE)
Zeitfenster: At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure
|
Incidence of major adverse cardiovascular events (MACE), including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death. |
At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Hauptermittler: Hui Dong, MD, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 2024-2484
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .